In this study, the specificity of the KIT antibodies was specifically validated by parallel staining of gut tissue on the same glass slide, which typically yielded KIT+ ICC (as further confirmed with double stains) and KIT+ mast cells. This evidence concerns the gene KIT and intrahepatic cholangiocarcinoma.